查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942992

酚紅市場按形態、通路、應用和最終用途產業分類，全球預測（2026-2032年）

Phenol Red Market by Form, Distribution Channel, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，酚紅市場價值將達到 5,572 萬美元，到 2026 年將成長到 5,965 萬美元，到 2032 年將達到 8,621 萬美元，複合年成長率為 6.43%。

關鍵市場統計數據
基準年 2025 5572萬美元
預計年份：2026年 5965萬美元
預測年份 2032 8621萬美元
複合年成長率 (%) 6.43%

酚紅的全面介紹：其生化作用、實驗室實際應用、供應鏈背景及其日益成長的重要性

酚紅作為一種可靠的pH指示劑和細胞培養基的標準添加劑，在生命科學實驗室和工業應用中佔據著重要的戰略地位。它在細胞培養基、診斷劑和工業試劑池中的廣泛應用，既體現了其化學穩定性，也反映了其在實驗室操作流程中的根深蒂固。過去十年間，酚紅的作用已不再局限於簡單的pH指示，其配方、來源和監管狀態都會影響實驗的可重複性、品管以及下游產品開發週期。

分析重塑酚紅需求的變革性變化，包括科學創新、永續性預期和監管壓力

多種顛覆性因素正在重塑酚紅產業格局，改變生產、配方和終端應用領域的重點。細胞和基因療法的進步、更複雜的生物製藥以及高通量篩檢方法的普及，推動了對具有明確雜質譜、嚴格公差和詳細可追溯性的試劑的需求。這項科學進步迫使供應商投資改善分析控制，並提供滿足治療研發和法規環境嚴苛要求的等級產品。

評估美國關稅在2025年對酚紅供應鏈、籌資策略和商業營運的累積影響

美國2025年生效的關稅政策帶來了一系列營運和商業上的複雜性，波及整個酚紅供應鏈，影響了原料成本、籌資策略和下游採購行為。關稅提高了進口原料和成品的成本，迫使買家重新評估其供應商組合，並尋求替代方案以在不影響品質的前提下降低額外成本。這種動態促使採購團隊立即考慮與國內或區域供應商簽訂短期契約，並評估持有獎勵和頻繁補貨的經濟效益。

針對酚紅相關人員的關鍵細分洞察，重點在於產品形態偏好、應用領域、終端用戶行為以及對分銷管道的影響

分段觀點有助於釐清酚紅生態系的需求模式，並突顯機會與風險領域。依應用領域分類，酚紅用戶涵蓋細胞培養基、pH指示劑溶液以及泳池和水療化學品，其中細胞培養基類別可細分為昆蟲細胞培養、哺乳動物細胞培養和微生物細胞培養。每種應用途徑都對品質和文件有獨特的要求。細胞培養應用通常需要更高的純度、檢驗的生產批次以及符合監管要求的分析證書。同時，pH指示劑溶液強調在各種化學條件下保持一致的顏色響應和穩定性，而泳池和水療組合藥物優先考慮成本效益和符合消費品法規的要求。

對美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、生產地點、法規環境和貿易趨勢進行區域分析

區域趨勢對酚紅的供應、監管應對和商業策略有顯著影響。在美洲，生產能力集中在成熟的化學和生命科學製造群中，這些集群利用了其接近性主要生物技術中心和大規模機構買家的優勢。這種集中化有利於快速週轉和提供先進的技術服務，但也使得區域政策變化和當地原料供應的影響更加集中。美洲的需求受到活躍的學術活動、不斷擴展的生物製藥研發管線以及日益重視供應鏈透明度的採購環境的影響。

戰略情報揭示酚紅生產商的生產投資、合作模式、創新重點和競爭地位

供應商和生產商的企業策略表明，他們採取了防禦性和成長性相結合的策略，旨在搶佔高價值細分市場並管控風險。對生產設施升級和分析能力的投資是反覆出現的主題，這使得企業能夠提供差異化等級的產品，提高純度指標，並完善符合監管和GMP要求的文件資料。隨著越來越多的企業尋求整合自身能力以加速客戶採納並縮短關鍵應用領域的應用時間，合作模式（包括與試劑配方商的共同開發契約以及與物流供應商的策略聯盟）正變得越來越普遍。

為產業領導者提供優先考慮且切實可行的建議，以降低供應風險、加速產品創新並加強分銷能力

產業領導者應採取一系列切實可行的措施，以增強韌性、維護科學誠信並實現商業性差異化。首先，採購團隊應實施供應商多元化策略，包括對二級生產商進行資格認證、建立區域緩衝庫存以及協商靈活的合約條款以適應監管檢驗的時間要求。將品質保證負責人納入供應商選擇和存取流程，可降低供應中斷的風險並保障實驗的可重複性。

透明的調查方法，清楚概述了資料來源、與關鍵專家的合作、抽樣方法、檢驗通訊協定和分析技術。

本分析所依據的研究結合了定性和定量方法，以確保對研究結果進行可靠的三角驗證。主要利害關係人包括來自學術界、製藥公司和生物技術公司的採購主管、品質保證專業人員和研發科學家，他們接受了結構化訪談。這些訪談揭示了營運重點、採購限制和產品性能預期。同時，對供應商的訪談和實地調查則提供了有關生產實踐、產能限制和品管系統的詳細情況。

一份權威、全面的分析報告，重點闡述了酚紅價值鏈中採購、研發優先級、法規遵從性和業務永續營運方面受到的影響。

從應用領域、產品形式、終端用戶產業和分銷管道收集的證據描繪出一幅產業圖景：技術要求與供應鏈考量緊密相連。治療藥物研發和受監管生產對高純度產品的需求，與學術機構和工業用戶對成本的合理要求並存，這為能夠以具有競爭力的價格提供有據可查的品質保證的供應商創造了市場細分機會。同時，政策措施和貿易趨勢也日益凸顯了供應鏈多元化和區域能力的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依形式分類的酚紅市場

  • 液體
  • 粉末

9. 按分銷管道分類的酚紅市場

  • 直銷
  • 分銷商/批發商
  • 電子商務

第10章 依應用分類的酚紅市場

  • 細胞培養基
    • 昆蟲細胞培養
    • 哺乳動物細胞培養
    • 微生物細胞培養
  • pH指示劑溶液
  • 泳池和水療中心化學品

第11章 以最終用途產業分類的酚紅市場

  • 學術研究
  • 生物技術
  • 化學製造
  • 製藥

第12章 酚紅市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 酚紅市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國酚紅市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國酚紅市場

第16章 中國酚紅市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • American Type Culture Collection
  • Amresco, LLC
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cayman Chemical Company
  • Hach Company
  • HiMedia Laboratories Limited
  • Merck KGaA
  • MilliporeSigma, LLC
  • Nacalai Tesque, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
Product Code: MRR-F847BD9C7177

The Phenol Red Market was valued at USD 55.72 million in 2025 and is projected to grow to USD 59.65 million in 2026, with a CAGR of 6.43%, reaching USD 86.21 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.72 million
Estimated Year [2026] USD 59.65 million
Forecast Year [2032] USD 86.21 million
CAGR (%) 6.43%

Comprehensive introduction to phenol red covering its biochemical role, practical laboratory applications, supply chain context and emerging relevance

Phenol red occupies a strategic position in life-science laboratories and industrial applications as a robust pH indicator and a routine additive in cell culture formulations. Its ubiquity in cell culture media, diagnostic reagents and industrial pools reflects both its chemical stability and the entrenched workflows of laboratory practice. Over the past decade, the compound's role has evolved beyond mere pH indication to become a material whose formulation, provenance and regulatory status affect experimental reproducibility, quality control and downstream product development timelines.

Scientific trends such as the rise of biologics, intensified academic research into cellular models, and expanding biotechnology pipelines have reinforced demand for high-purity reagents and greater assurance of lot-to-lot consistency. Concurrently, manufacturers and users face heightened scrutiny around supply chain transparency, raw material sourcing and environmental compliance. These pressures intersect with operational realities: lead times, production capacity, packaging formats and distribution routes all influence the availability of phenol red for critical applications.

Taken together, the landscape requires stakeholders to balance technical specifications with procurement discipline. Laboratories prioritize validated grades and certificates of analysis, while producers must manage scale, quality control and regulatory documentation. As such, a comprehensive understanding of phenol red's functional role, supply dynamics and quality expectations is essential for leaders who must align scientific needs with operational and commercial strategies.

Analysis of transformative shifts reshaping phenol red demand including scientific innovation, sustainability expectations and regulatory pressure

Several transformative forces are reshaping the phenol red landscape, altering emphases across production, formulation and end-use behavior. Advances in cell and gene therapies, more complex biologics and high-throughput screening approaches are increasing demand for reagents with defined impurity profiles, tighter tolerances and detailed traceability. This scientific progression pressures suppliers to invest in improved analytical controls and to offer grades that meet the stringent needs of therapeutic development and regulated environments.

Sustainability expectations and regulatory tightening are compelling manufacturers to re-evaluate raw material sourcing and manufacturing footprints. Buyers increasingly prioritize suppliers that can demonstrate lower environmental impact, responsible chemical management and compliance with evolving chemical regulations. As a result, producers are adapting by optimizing processes to reduce waste, improve solvent recovery and adopt greener chemistries where feasible, which in turn affects cost structures and capital allocation.

Digital transformation is another pivotal shift. Laboratory automation, e-commerce procurement channels and enhanced traceability systems are changing how buyers discover, qualify and transact for phenol red. Real-time inventory visibility and digital quality documentation shorten procurement cycles and enable closer alignment between demand forecasts and production planning. Finally, market fragmentation through product differentiation-such as specialized formulations and pre-qualified lots for critical applications-has created new commercial dynamics that prioritize flexibility, responsiveness and value-added services alongside traditional product metrics.

Evaluation of the cumulative effects of United States tariff actions in 2025 on phenol red supply chains, procurement strategies and commercial operations

The tariff measures implemented by the United States in 2025 introduced a set of operational and commercial complications that ripple through the phenol red supply chain, affecting raw material costs, sourcing strategies and downstream procurement behavior. Tariffs elevated the cost basis for imported inputs and imported finished goods, prompting buyers to reassess supplier portfolios and to explore alternatives that mitigate incremental expense without compromising quality. This dynamic has created immediate incentives for procurement teams to seek nearer-term contracts with domestic or regional suppliers and to evaluate the economics of stockholding versus frequent replenishment.

In practical terms, the tariffs intensified scrutiny of total landed cost and of non-tariff barriers such as customs clearance times and additional documentation. The result was an increase in preference for suppliers with established logistical capabilities and localized warehousing that could absorb customs friction. For manufacturers, the policy environment accelerated conversations around regional capacity expansion and dual-sourcing, as firms sought to reduce vulnerability to trade policy shifts and to maintain continuity for critical customers in regulated sectors.

Operationally, the tariffs also influenced product pricing strategies and contract negotiations. Companies with forward-looking procurement functions used hedging mechanisms, indexed contract clauses and renegotiated terms to preserve margins and maintain supply continuity. Meanwhile, quality assurance and regulatory teams needed to validate substitutions where suppliers changed sourcing in response to cost pressure. Taken together, the tariffs in 2025 catalyzed a reorientation toward supply chain resilience, intensified margin management and a renewed emphasis on the strategic alignment of procurement, production and regulatory functions.

Key segmentation-driven insights revealing product form preferences, application niches, end user behavior and distribution channel implications for phenol red stakeholders

A segmentation-led view clarifies demand patterns and illuminates where opportunities and risks concentrate across the phenol red ecosystem. Based on Application, users span Cell Culture Media, pH Indicator Solutions and Pool and Spa Chemicals, with the Cell Culture Media category further divided into Insect Cell Culture, Mammalian Cell Culture and Microbial Cell Culture. Each application pathway imposes distinct quality and documentation requirements: cell culture applications typically demand higher purity, validated production lots and certificates of analysis that align with regulatory submissions, whereas pH indicator solutions emphasize consistent color response and stability under diverse chemical conditions, and pool and spa formulations prioritize cost efficiency and regulatory compliance for consumer-facing products.

Based on Form, offerings exist as Liquid and Powder, and this distinction influences logistics, shelf life and unit economics. Liquid formulations offer convenience and reduced preparation time for end users but incur higher shipping weight and specialized packaging, while powder formats provide advantages in transport efficiency, storage longevity and flexible reconstitution for diverse lab protocols. Storage and handling considerations therefore drive buyer preference in tandem with institutional procurement policies.

Based on End Use Industry, phenol red serves Academic Research, Biotechnology, Chemical Manufacturing and Pharmaceutical sectors, each with unique procurement cycles, quality expectations and compliance obligations. Academic laboratories may prioritize cost-effectiveness and rapid availability, whereas pharmaceutical and biotechnology customers require rigorous supply chain traceability and quality systems for regulatory submissions. Based on Distribution Channel, access to product is facilitated through Direct Sales, Distributors/Wholesalers and E-Commerce, with each route affecting lead times, technical support and purchasing behaviors. Direct sales relationships enable customized service and contract terms for large users, distributors provide breadth and regional reach for mid-market buyers, and e-commerce platforms deliver convenience and rapid fulfillment for smaller laboratories.

Regionally focused intelligence on demand drivers, production hubs, regulatory environments and trade dynamics across Americas, EMEA and Asia-Pacific territories

Regional dynamics materially influence supply availability, regulatory engagement and commercial strategies for phenol red. In the Americas, production capabilities are concentrated around established chemical and life-science manufacturing clusters that benefit from proximity to major biotech hubs and large institutional buyers. This concentration supports short lead times and high levels of technical service, but it also concentrates exposure to regional policy changes and local feedstock availability. Demand in the Americas is shaped by robust academic activity, expanding biopharma pipelines and a procurement environment that increasingly values supply chain transparency.

Europe, Middle East & Africa presents a heterogeneous landscape where stringent chemical regulations and a strong emphasis on sustainability drive supplier credentialing and documentation. Buyers in these jurisdictions place premium value on environmental compliance, certification and reliable quality systems. Market participants operating here must navigate diverse regulatory frameworks and a complex trade environment that rewards local compliance expertise and adaptive logistics. Cross-border trade within the region often requires meticulous attention to labeling, transport standards and chemical safety dossiers.

Asia-Pacific is characterized by both large manufacturing capacity and rapidly growing end-use demand, particularly in biotechnology research and industrial chemical applications. Production hubs across the region offer cost advantages and scale, while strong domestic innovation ecosystems are fueling demand for higher-grade reagents. However, the region's trade flows and logistics networks can be sensitive to policy shifts and raw material sourcing constraints, prompting international buyers to weigh lead time, quality certification and supplier reliability when selecting partners. Across all regions, strategic inventory placement and diversified sourcing remain critical levers for resilience.

Strategic intelligence revealing manufacturing investments, collaboration models, innovation priorities and competitive positioning of phenol red producers

Corporate strategies among suppliers and producers reveal a blend of defensive and growth-oriented actions designed to manage risk while capturing higher-value segments. Investment in manufacturing upgrades and analytical capabilities has been a recurring theme, enabling firms to offer differentiated grades with enhanced purity metrics and expanded documentation packages that meet regulatory and GMP-adjacent expectations. Collaboration models, including co-development agreements with reagent formulators and strategic partnerships with logistics providers, have become more commonplace as companies seek to integrate capabilities that accelerate customer onboarding and reduce time-to-use for critical applications.

Competition is further defined by the degree of vertical integration and geographic footprint. Manufacturers that vertically integrate raw material processing through finished product packaging enjoy tighter control of quality and supply continuity, which can be a decisive advantage for customers in regulated industries. Conversely, specialized producers that focus on high-purity grades leverage technical expertise, niche certifications and responsive customer support to differentiate from commodity suppliers.

Innovation priorities center on product customization, faster lead times and digital services such as lot-level traceability portals and online technical documentation. Firms that couple technical competence with flexible commercial models-such as tailored supply agreements, managed inventory and technical training-tend to secure longer-term engagements. Mergers and acquisitions, selective capacity expansion and targeted investments in sustainability and compliance capabilities are among the primary mechanisms companies use to sustain competitive positioning and to respond to evolving customer expectations.

Prioritized and actionable recommendations for industry leaders to mitigate supply risk, accelerate product innovation and strengthen distribution capabilities

Industry leaders must adopt a pragmatic set of actions that enhance resilience, preserve scientific integrity and create commercial differentiation. First, procurement teams should implement supplier diversification strategies that include qualifying secondary producers, establishing regional buffer inventories and negotiating flexible contract terms that accommodate regulatory validation timelines. Embedding quality assurance representatives in supplier selection and onboarding processes will reduce the risk of disruptive substitutions and protect experimental reproducibility.

Second, companies should invest in product and process innovation that aligns with customer needs. This means developing documented, traceable grades for therapeutic development, offering both liquid and powder formats optimized for end-use scenarios, and delivering value-added services such as lot-specific analytical dossiers and stability data. R&D investments that reduce impurities and enhance shelf stability translate directly into reduced downstream risk for customers and competitive premium for suppliers.

Third, strengthen distribution and commercial channels by leveraging direct sales for large institutional customers, partnerships with distributors for regional reach, and optimized e-commerce experiences for smaller buyers. Digital tools that provide real-time inventory visibility, certificate access and ordering automation improve customer satisfaction and reduce procurement friction. Finally, engage proactively with regulators and industry consortia to anticipate compliance shifts, and implement environmental and chemical stewardship programs that respond to buyer expectations and reduce long-term operational risk.

Transparent research methodology describing data sources, primary expert engagement, sampling approaches, validation protocols and analytical techniques

The research underpinning this analysis combined qualitative and quantitative approaches to ensure robust, triangulated findings. Primary engagement included structured interviews with procurement leads, quality assurance professionals and R&D scientists across academic, pharmaceutical and biotechnology organizations. These conversations illuminated practical priorities, procurement constraints and product performance expectations. In parallel, supplier interviews and site-level inquiries provided visibility into manufacturing practices, capacity constraints and quality control regimes.

Secondary research relied on technical literature, regulatory guidance documents and publicly available company disclosures to contextualize primary insights and to map relevant policy drivers. Data triangulation was achieved by cross-referencing interview evidence with operational indicators such as production announcements, import/export trends and industry commentary. Analytical techniques included comparative supplier profiling, scenario analysis for supply chain disruption, and qualitative synthesis to translate technical nuances into operational implications.

Validation protocols involved follow-up consultations with subject-matter experts to vet key assumptions and to refine recommendations. Limitations of the study are acknowledged, including potential variability in supplier disclosures and evolving policy environments that require periodic reassessment. Where applicable, sensitivity checks were applied to non-sensitive operational scenarios to confirm the robustness of conclusions and to inform prioritized action items.

Conclusive synthesis highlighting procurement, R&D prioritization, regulatory engagement and operational resilience implications across the phenol red value chain

The evidence gathered across applications, forms, end-use industries and distribution channels points to a sector in which technical requirements and supply chain considerations are tightly coupled. High-purity demands from therapeutic development and regulated manufacturing coexist with pragmatic cost sensitivity in academic and industrial users, creating segmentation opportunities for suppliers that can deliver documented quality at competitive price points. At the same time, policy measures and trade dynamics have heightened the premium on supply chain diversification and regional capability.

For stakeholders, the strategic implications are clear: align procurement processes with technical teams to ensure specification fidelity; invest in supplier qualification and traceability to mitigate substitution risk; and adopt flexible distribution strategies that combine direct, distributor and digital channels. R&D prioritization should emphasize impurity reduction, formulation flexibility and stability gains that directly address user pain points. Regulatory engagement and sustainability commitments will continue to be differentiators that affect buyer selection and long-term partnerships.

Overall, a combination of operational rigor, technical differentiation and proactive policy engagement will enable organizations to navigate current complexities and to position themselves advantageously as scientific advancements and commercial demands evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Phenol Red Market, by Form

  • 8.1. Liquid
  • 8.2. Powder

9. Phenol Red Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Distributors/Wholesalers
  • 9.3. E-Commerce

10. Phenol Red Market, by Application

  • 10.1. Cell Culture Media
    • 10.1.1. Insect Cell Culture
    • 10.1.2. Mammalian Cell Culture
    • 10.1.3. Microbial Cell Culture
  • 10.2. pH Indicator Solutions
  • 10.3. Pool And Spa Chemicals

11. Phenol Red Market, by End Use Industry

  • 11.1. Academic Research
  • 11.2. Biotechnology
  • 11.3. Chemical Manufacturing
  • 11.4. Pharmaceutical

12. Phenol Red Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Phenol Red Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Phenol Red Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Phenol Red Market

16. China Phenol Red Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. American Type Culture Collection
  • 17.6. Amresco, LLC
  • 17.7. Avantor, Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. Cayman Chemical Company
  • 17.11. Hach Company
  • 17.12. HiMedia Laboratories Limited
  • 17.13. Merck KGaA
  • 17.14. MilliporeSigma, LLC
  • 17.15. Nacalai Tesque, Inc.
  • 17.16. Santa Cruz Biotechnology, Inc.
  • 17.17. Thermo Fisher Scientific Inc.
  • 17.18. Tokyo Chemical Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHENOL RED MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHENOL RED MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHENOL RED MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHENOL RED MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHENOL RED MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHENOL RED MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHENOL RED MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHENOL RED MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHENOL RED MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHENOL RED MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHENOL RED MARKET SIZE, BY DISTRIBUTORS/WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHENOL RED MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHENOL RED MARKET SIZE, BY INSECT CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHENOL RED MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHENOL RED MARKET SIZE, BY MICROBIAL CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHENOL RED MARKET SIZE, BY PH INDICATOR SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHENOL RED MARKET SIZE, BY POOL AND SPA CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHENOL RED MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHENOL RED MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHENOL RED MARKET SIZE, BY CHEMICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHENOL RED MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHENOL RED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PHENOL RED MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHENOL RED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. GCC PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 113. GCC PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. G7 PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. G7 PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 131. G7 PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NATO PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 134. NATO PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. NATO PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 137. NATO PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PHENOL RED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA PHENOL RED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA PHENOL RED MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA PHENOL RED MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA PHENOL RED MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA PHENOL RED MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA PHENOL RED MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)